IP Library Granted Patent US 11,135,033
Granted Patent B2
US 11,135,033 · App. 16/146,815 · Granted Oct 5, 2021

Tissue localization device and method of use thereof

Inventors: George D. Hermann (Los Altos Hills, CA); Jonathan M. Olson (San Jose, CA); Michael J. Drews (Palo Alto, CA); Gail S. Lebovic (Frisco, TX); David B. Willis (Portland, OR)
Assignee: HOLOGIC, INC.
A61B90/39A61B17/3468A61B2017/3409A61B2017/3413A61B2090/3908A61B2090/3925A61B2090/3962A61B2090/3987A61B2090/3991
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,135,033
App. No.
16/146,815
Granted
Oct 5, 2021
Kind
B2
Abstract

Tissue localization devices and methods of localizing tissue using tissue localization devices are disclosed. The tissue localization device can comprise a handle comprising a delivery control, a delivery needle extending out from the handle, and a localization element within the delivery needle. The localization element can be deployed out of the delivery needle or retracted back into the delivery needle when the delivery control is translated in a first direction or a second direction, respectively. The localization element can be coupled to a flexible tracking wire.

Claims (17)

1. A tissue localization device, comprising:

a handle configured to be held using one hand;

a delivery needle extending from the handle, wherein the delivery needle comprises a needle lumen;

a pusher configured to slidably translate within the needle lumen; and

a localization marker detachably coupled to the pusher and configured to form into a partial-loop configuration when deployed out of the delivery needle,

wherein the localization marker is slidably translatable within the needle lumen by translating a slidable delivery control in a first longitudinal direction along a surface of the handle,

wherein the localization marker is translatable before release of the localization marker from the tissue localization device, and

wherein the pusher includes one or more spring-loaded pins moveable between a compressed position and an extended position,

wherein:

when in the compressed position, the pusher is arranged and configured to slidably translate within the needle lumen; and

when in the extended position, the one or more spring-loaded pins are received within one or more holes formed in the handle to prevent the pusher from slidably translating within the needle lumen.

2. The device of claim 1 , wherein the pusher is slidably translatable within the needle lumen in response to the translation of the slidable delivery control.

3. The device of claim 1 , wherein the localization marker comprises a proximal frame portion and the proximal frame portion is configured to detachably interlock with a recess defined along the pusher.

4. The device of claim 1 , wherein the localization marker is retractable back into the needle lumen before release from the tissue localization device needle by translating the slidable delivery control in a second longitudinal direction opposite the first longitudinal direction along the surface of the handle, wherein the localization marker is retractable before release of the localization marker from the tissue localization device.

5. The device of claim 1 , where the pusher is coupled to the slidable delivery control via a connector extending through a slot defined along a dorsal side of the handle.

6. The device of claim 1 , wherein the localization marker is coupled to a tracking wire and the tracking wire is configured to align secant to the partial-loop configuration of the localization marker upon release of the localization marker from the tissue localization device.

7. The device of claim 1 , wherein the one or more spring-loaded pins are received within the one or more holes when the pusher has reached a designated position relative to the handle corresponding to the localization marker being fully deployed and having separated from the pusher.

Assignments (4)
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
MERGER AND CHANGE OF NAME Recorded Jul 13, 2021
From: FOCAL THERAPEUTICS, INC.; HOLOGIC, INC.
To: HOLOGIC, INC.
Reel/Frame 056835/0532 →
SECURITY INTEREST Recorded Oct 14, 2019
From: HOLOGIC, INC.; CYNOSURE, LLC; CYTYC CORPORATION; FAXITRON BIOPTICS, LLC; FOCAL THERAPEUTICS, INC.; GEN-PROBE INCORPORATED
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 050719/0701 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 28, 2018
From: HERMANN, GEORGE D.; OLSON, JONATHAN M.; DREWS, MICHAEL J.; LEBOVIC, GAIL S.; WILLIS, DAVID B.
To: FOCAL THERAPEUTICS INC.
Reel/Frame 047164/0156 →
Continuity (4)
Continuation 15488358 · Apr 14, 2017
Provisional Application 62448307 · Jan 19, 2017
Provisional Application 62322729 · Apr 14, 2016
Related Publication 20190029773A1 · Jan 31, 2019